Louisville, KY, June 12, 2017 (GLOBE NEWSWIRE) -- Appriss Health, provider of the most comprehensive platform for substance use disorder in the U.S., today announced it has recently signed an agreement with the Arizona Board of Pharmacy to enable integration of controlled substance prescription information into electronic health records (EHRs) and pharmacy management systems statewide. The solution, PMP Gateway, can enable access to data, analytics, insight, tools and resources from prescription drug monitoring programs (PDMPs) within care team workflows in real-time, at the point-of-care to improve patient safety and outcomes.
PMP Gateway is a technology that provides a variety of options for health IT systems to integrate PDMP information and functionality into prescriber and pharmacist workflows. Prior to PMP Gateway, prescribers and pharmacists had to log into separate websites to retrieve a patient's prescriptions and then cross-reference this data with a patient's health information in other systems. The PMP Gateway solution provides instant access to the patient's prescription drug information and associated insights and resources within the EHR and pharmacy dispensing system.
This announcement follows a January implementation in Arizona of Appriss Health’s PMP AWARxE prescription monitoring program solution, which will include expanded features such as enhanced prescriber reports, advanced analytics and an integration with state licensing board databases that will streamline the PMP registration process. PMP AWARxE allows pharmacies to fulfill mandatory controlled substance dispensation reporting requirements and offers secure accessibility to data across state lines. Appriss Health’s PDMP solutions are currently live in 42 states and municipalities.
Arizona is now the third state committed to implement a statewide, enterprise license for in-workflow PDMP integration. These enhancements to the state PDMP will position Arizona to continue a successful implementation of State Senate Bill 1283, which will require medical practitioners to request a patient prescription history prior to prescribing certain controlled substances, including opioids.
“We want to recognize Appriss Health as our trusted partner in helping to enact the mission of the Arizona State Board of Pharmacy – to protect the health, safety and welfare of the citizens of Arizona,” said Kam Gandhi, PharmD, Executive Director, Arizona State Board of Pharmacy. “By providing prescription drug information instantly, at the time and place of patient care, we expect to see an increase in information usage to improve patient safety and outcomes while we simultaneously work to continue to combat prescription drug addiction, overdose and death in Arizona.”
The benefits of EHR integration into state PDMPs have been widely-recognized as beneficial to improving patient safety, mitigating drug diversion and ensuring compliance.
“Arizona is truly on the forefront in addressing substance use disorder,” said Rob Cohen, President, Appriss Health. “We want to thank the Arizona Board of Pharmacy for recognizing the need to take immediate action to address the growing, nationwide problems associated with prescription drug addiction and abuse by empowering all of their physicians and pharmacists statewide with the right information they need, right at their fingertips, to make better decisions about prescribing and dispensing controlled substances.”
About Appriss Health
Appriss Health provides the nation's most comprehensive platform for early identification, prevention and management of substance use disorder (SUD). We provide state government agencies with the most advanced repository of controlled substance dispensing data, and deliver real-time clinical decisioning support, critical insights and interventions to physicians, pharmacists, and care team members through millions of patient encounters each year. Our solutions enable healthcare providers, pharmacists and care team members to assess and manage clinical risk in order to positively impact patient safety and population health outcomes. For more information, please visit www.apprisshealth.com.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/ec53a1df-3ea7-48d4-92a1-e7432fa6b45f